Found 0 matching trials
A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma PHASE1 This study will evaluate the safety, tolerability, pharmacokinetics, and ac...
Show More Location
Royal Adelaide Hospital
Learn More & Join Trial
A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome PHASE2 The purpose of this study is to determine the activity of tamibarotene in p...
Show More Location
Multiple Locations
Learn More & Join Trial
Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma PHASE2 This trial aimed to investigate the therapeutic efficacy of daratumumnab pl...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma PHASE1 Multiple myeloma (MM) accounts for more than 10% of all blood cancers and 1...
Show More Location
Sylvester Comprehensive Cancer Center /ID# 228817
Learn More & Join Trial
Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma PHASE2 The goal of this clinical study is to learn more about the safety and dosin...
Show More Location
Arizona Oncology Associates , PC - HOPE
Learn More & Join Trial
Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM PHASE1 This phase II clinical trial design with a safety run-in period will be use...
Show More Location
Multiple Locations
Learn More & Join Trial
Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma PHASE2 The goal of this phase 2 clinical trial is to learn if patients with Multip...
Show More Location
Karmanos Cancer Institute
Learn More & Join Trial
Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD PHASE2 This is an open-label, multicenter, Phase 2 study in subjects with newly di...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma PHASE2 The purpose of the study is to compare the efficacy of QLS32105 (SC) in com...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma PHASE3 The purpose of this study is to compare the effectiveness of daratumumab wh...
Show More Location
Multiple Locations
Learn More & Join Trial